GlassScriptPhysician profile
David P Rapaport
NPI 1134271521
$577,855.18
in general payments reported to CMS, 2019-2025
10 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $489 · 2020: $938 · 2021: $103K · 2022: $213K · 2023: $184K · 2024: $77K · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $240K · Honoraria: $16K · Consulting Fee: $3,850 · Food and Beverage: $761 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $240,036.00 |
| Honoraria | $15,807.17 |
| Consulting Fee | $3,850.00 |
| Food and Beverage | $761.35 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $290,350.54 | 2019-2022 | |
| Abbvie INC. | $242,465.36 | 2023-2025 | |
| Acelrx Pharmaceuticals, INC. | $28,408.28 | 2021-2023 | Dsuvia |
| Lumenis Be LTD | $15,807.17 | 2024 | |
| Sientra, INC. | $288.61 | 2019 | |
| Galderma Laboratories, L.P. | $183.11 | 2020 | |
| Zoll Respicardia, INC. | $140.00 | 2019 | |
| Motiva USA, LLC | $130.89 | 2024 | |
| Revance Therapeutics, INC. | $59.55 | 2025 | Daxxify |
| Solta Medical, A Division of Bausch Health US, LLC | $21.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rapaport listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.